From basic research to biologics production, viral systems play an important role in the large-scale production of recombinant proteins. The production and purification of viral particles is a multi-step process that needs to be carefully optimized to maximize viral titers and protein yield. Centrifugation can enhance your viral harvesting, isolation, purification, and characterization workflow.
Following transformation and cellular viral amplification, cells are subjected to a low force centrifugation step to separate soluble virus from cells containing virus. Remember to retain the supernatant as well, which contains secreted virus that can be purified for downstream applications. Lyse the separated cells by chemical or mechanical sheering to release intracellular virus. Then centrifuge the solution to sediment the heavy cellular fragments and debris, leaving the lighter viral fraction in solution. Retain the supernatant and transfer to a new centrifuge tube.
Viral particles can be precipitated from the supernatant using polyethelyene glycol, followed by low speed centrifugation. This creates a pellet containing viral particles. Wash the pellet with sodium benzoate. The pellet is resuspended and centrifuged again to further clarify the viral mixture from cellular debris and other chemicals from the previous steps. The viral mixture is now contained in the supernatant.
High performance, high capacity centrifugation can maximize yield, improving viral fraction purity. Density gradient ultracentrifugation is used to isolate active virus on the basis of its size and density, with the additional benefit of purifying fully loaded virus from empty particles, incomplete virus, proteins, and any residual cellular debris.
Typically, it begins with a step gradient centrifugation using either sucrose, iodixanol, or cesium chloride to separate viral particles based on migration rate.
Viral density can range from 1.14 to 1.24 g/ml, which is denser than both empty particles and cellular proteins.
The viral band is then carefully removed by either syringe extraction or fractionation. It is then subjected to rate zonal centrifugation to separate viral particles on the basis of size and mass. Analytical ultracentrifugation is the preferred choice to characterize the quality and purity of viral particles.
Centrifugation can enhance your viral purification workflow as part of a comprehensive system. To learn more about viral particle isolation, please visit research areas in our Resource Center.
ご登録いただいた皆様に、どこよりも早く最新情報をお届けします。ぜひご登録ください!
© 2000-2025
ベックマン・コールター株式会社. All rights reserved.
Beckman Coulter、Beckman Coulter ロゴ、製品およびサービスマークは米国およびその他の国におけるBeckman Coulter, Inc. の登録商標です。
その他すべての商標はそれぞれの所有者の財産です。 それぞれの国によりすべての製品が入手できない場合があります。製品入手の可否及び規制内容は各国の規制対応に準じます。各製品は次の規制表示のいずれかに該当いたします。
IVD:In Vitro Diagnostic Products (体外診断用医薬品)該当製品は米国FDA規制に準じます。
日本国内規制での体外診断用医薬品に該当しない場合があります。
日本における体外診断用医薬品に関してはこちらをご確認ください。
ASR:Analyte Specific Reagents
該当製品は”Analyte Specific Reagents. Analytical and performance characteristics are not established.”のラベルが添付されます。
CE: In Vitro Diagnostic該当製品及びヨーロッパ規制(98/79/EC)に順じます。
(製品はヨーロッパ規制98/79/EC以外にCEマークが添付される場合が有ります。)
RUO: Research Use Only(研究使用限定)
該当製品は”Research Use Only(研究使用限定)”のラベルが添付されています。
LUO: Laboratory Use Only(研究使用限定)
該当製品は”Laboratory Use Only(研究使用限定)”のラベルが添付されています。
No Regulatory Status:
医療用機器又は規制商品ではありません。診断又は治療行為には使用できません。